ONCOINVENT ASA
Home - Oncoinvent
Committed to developing new innovative radiopharmaceutical products for better treatment options for cancer patients Watch company presentation, or download (.pdf) Latest news and press releases ALL202420232022202120202019201820172016 15. May. 2024 Oncoinvent to Present at Cantor Fitzgerald Frontiers in Radiopharma Virtual Summit 2. Apr. 2024 Oncoinvent Announces Changes to its Board of Directors and Formation of Scientific ... Read more
Keywords
researchdevelopment worknatural sciencesengineeringtechnologymedicineagricultureinterdisciplinary research
Links
Organization
- CEO
- ØS
Øystein Soug1969
- Chairman of the board
- Years since formation
- 14 years
- since Aug 11, 2010
- Type
- Public limited company
- VAT registered
- Yes
- Number of employees
- 44
Ownership
- Number of shares and share classes
- 19,394,295
- 1 share class
- Total number of shareholders
- 445
- 168 companies, 277 persons
Financials
- Total operating income 2023
- 5,790,000
- NOK
- Annual total result 2023
- -143,621,000
- NOK
- Total equity 2023
- 54,931,000
- NOK
Last update: Dec 11, 2024
Management
Management / administration
Name | Role | Shares |
---|---|---|
ØS 1969 | Managing Director/CEO | - |
Board
Name | Role | Shares |
---|---|---|
AC | Board Member | - |
Chairman | - | |
Board Member | - | |
Board Member | - | |
KG 1964 | Board Member | - |
Board Member | - | |
MD 1988 | Observer | - |
Others
Name | Role | Shares |
---|---|---|
Auditor | - |
Top 10 individual shareholders
Name | Role | Shares |
---|---|---|
RH | - | 20.08 % directly 3.5 % indirectly 16.59 % |
ØS | - | 3.26 % indirectly |
EH | - | 2.95 % indirectly |
TL 1956 | - | 2.27 % directly 1.75 % indirectly 0.52 % |
ML 1956 | - | 2.06 % indirectly |
TM 1971 | - | 1.99 % indirectly |
EC | - | 1.99 % indirectly |
CS | - | 1.56 % indirectly |
ÅP | - | 1.52 % indirectly |
TB | - | 1.43 % directly |
Last update: Sep 5, 2024
Ownership
Company shareholders
Name | Share class | Number of shares | Share |
---|---|---|---|
NO0010779341 | 3,217,223 | 16.59 % | |
NO0010779341 | 1,771,076 | 9.13 % | |
NO0010779341 | 919,772 | 4.74 % | |
NO0010779341 | 786,230 | 4.05 % | |
NO0010779341 | 762,530 | 3.93 % | |
NO0010779341 | 690,110 | 3.56 % | |
RH | NO0010779341 | 678,000 | 3.5 % |
NO0010779341 | 632,500 | 3.26 % | |
NO0010779341 | 546,145 | 2.82 % | |
NO0010779341 | 450,000 | 2.32 % | |
NO0010779341 | 427,151 | 2.2 % | |
NO0010779341 | 400,000 | 2.06 % | |
TL 1956 | NO0010779341 | 340,250 | 1.75 % |
TB | NO0010779341 | 277,600 | 1.43 % |
NO0010779341 | 276,915 | 1.43 % | |
NO0010779341 | 261,250 | 1.35 % | |
NO0010779341 | 235,200 | 1.21 % | |
NO0010779341 | 215,000 | 1.11 % | |
NO0010779341 | 210,261 | 1.08 % | |
NO0010779341 | 206,923 | 1.07 % | |
NO0010779341 | 186,706 | 0.96 % | |
NO0010779341 | 160,000 | 0.82 % | |
NO0010779341 | 160,000 | 0.82 % | |
NO0010779341 | 136,720 | 0.7 % | |
NO0010779341 | 134,000 | 0.69 % | |
KH | NO0010779341 | 132,148 | 0.68 % |
NO0010779341 | 131,000 | 0.68 % | |
ØN 1971 | NO0010779341 | 120,000 | 0.62 % |
NO0010779341 | 111,440 | 0.57 % | |
OL 1958 | NO0010779341 | 107,000 | 0.55 % |
NO0010779341 | 105,000 | 0.54 % | |
NO0010779341 | 100,000 | 0.52 % | |
NO0010779341 | 96,160 | 0.5 % | |
NO0010779341 | 96,153 | 0.5 % | |
NO0010779341 | 76,635 | 0.4 % | |
NO0010779341 | 75,000 | 0.39 % | |
ØI | NO0010779341 | 74,631 | 0.38 % |
NO0010779341 | 70,000 | 0.36 % | |
NO0010779341 | 65,000 | 0.34 % | |
NO0010779341 | 63,300 | 0.33 % | |
NO0010779341 | 61,000 | 0.31 % | |
NO0010779341 | 60,000 | 0.31 % | |
NO0010779341 | 58,850 | 0.3 % | |
NO0010779341 | 57,692 | 0.3 % | |
NO0010779341 | 53,000 | 0.27 % | |
AL 1946 | NO0010779341 | 50,000 | 0.26 % |
NO0010779341 | 50,000 | 0.26 % | |
NO0010779341 | 50,000 | 0.26 % | |
NO0010779341 | 50,000 | 0.26 % | |
NO0010779341 | 48,189 | 0.25 % | |
AL | NO0010779341 | 46,000 | 0.24 % |
NO0010779341 | 45,000 | 0.23 % | |
NO0010779341 | 45,000 | 0.23 % | |
DF | NO0010779341 | 43,517 | 0.22 % |
NO0010779341 | 40,500 | 0.21 % | |
NO0010779341 | 40,000 | 0.21 % | |
NO0010779341 | 40,000 | 0.21 % | |
GS | NO0010779341 | 39,290 | 0.2 % |
NO0010779341 | 38,800 | 0.2 % | |
HP 1955 | NO0010779341 | 38,700 | 0.2 % |
ES | NO0010779341 | 36,300 | 0.19 % |
NO0010779341 | 36,000 | 0.19 % | |
NO0010779341 | 33,988 | 0.18 % | |
NO0010779341 | 33,650 | 0.17 % | |
NO0010779341 | 33,000 | 0.17 % | |
NO0010779341 | 32,500 | 0.17 % | |
NO0010779341 | 32,500 | 0.17 % | |
NO0010779341 | 30,000 | 0.15 % | |
OA | NO0010779341 | 29,750 | 0.15 % |
SH | NO0010779341 | 29,300 | 0.15 % |
LS 1949 | NO0010779341 | 28,528 | 0.15 % |
NO0010779341 | 27,900 | 0.14 % | |
NO0010779341 | 27,896 | 0.14 % | |
NO0010779341 | 27,000 | 0.14 % | |
NO0010779341 | 26,515 | 0.14 % | |
GL 1980 | NO0010779341 | 26,500 | 0.14 % |
NO0010779341 | 26,000 | 0.13 % | |
AB 1981 | NO0010779341 | 25,500 | 0.13 % |
EL 1984 | NO0010779341 | 25,400 | 0.13 % |
NO0010779341 | 25,000 | 0.13 % | |
MA | NO0010779341 | 25,000 | 0.13 % |
NO0010779341 | 25,000 | 0.13 % | |
JW 1978 | NO0010779341 | 24,800 | 0.13 % |
NO0010779341 | 23,500 | 0.12 % | |
NO0010779341 | 23,300 | 0.12 % | |
NO0010779341 | 23,300 | 0.12 % | |
JL 1969 | NO0010779341 | 23,134 | 0.12 % |
TB 1949 | NO0010779341 | 22,300 | 0.11 % |
HL | NO0010779341 | 21,550 | 0.11 % |
TE 1960 | NO0010779341 | 20,930 | 0.11 % |
NO0010779341 | 20,000 | 0.1 % | |
NO0010779341 | 20,000 | 0.1 % | |
TF 1935 | NO0010779341 | 20,000 | 0.1 % |
NO0010779341 | 20,000 | 0.1 % | |
NO0010779341 | 20,000 | 0.1 % | |
NO0010779341 | 20,000 | 0.1 % | |
NO0010779341 | 20,000 | 0.1 % | |
NO0010779341 | 20,000 | 0.1 % | |
NO0010779341 | 20,000 | 0.1 % | |
NO0010779341 | 20,000 | 0.1 % |
Last update: May 24, 2024
Financials
in NOK
Summary
Year | 2023 | 2022 | 2021 |
---|---|---|---|
Total operating income | 5,790,000 | 6,282,500 | 11,083,018 |
Annual Total Result | -143,621,000 | -103,756,765 | -80,288,555 |
Total assets | 98,734,000 | 222,244,881 | 317,620,406 |
Total liabilities | 43,803,000 | 26,573,144 | 18,439,580 |
Total equity | 54,931,000 | 195,671,737 | 299,180,826 |
P&L
Year | 2023 | 2022 | 2021 |
---|---|---|---|
Total operating income | 5,790,000 | 6,282,500 | 11,083,018 |
Total operating costs | 153,215,000 | 114,370,066 | 91,925,009 |
Operating result | -147,425,000 | -108,087,566 | -80,841,991 |
Financial income/costs | 3,804,000 | 4,330,801 | 553,436 |
Profit before tax | -143,621,000 | -103,756,765 | -80,288,555 |
Total tax & extraordinary income/cost | 0 | 0 | 0 |
Annual Total Result | -143,621,000 | -103,756,765 | -80,288,555 |
Balance overview
Year | 2023 | 2022 | 2021 |
---|---|---|---|
Total fixed assets | 40,810,000 | 9,532,261 | 10,335,350 |
Total current assets | 57,924,000 | 212,712,620 | 307,285,056 |
Total assets | 98,734,000 | 222,244,881 | 317,620,406 |
Short term debt | 35,456,000 | 26,573,144 | 18,439,580 |
Long term debt | 8,347,000 | 0 | 0 |
Total liabilities | 43,803,000 | 26,573,144 | 18,439,580 |
Contributed capital | 551,491,000 | 539,587,150 | 539,339,469 |
Retained earnings | -496,560,000 | -343,915,413 | -240,158,643 |
Total equity | 54,931,000 | 195,671,737 | 299,180,826 |
Total equity and liabilities | 98,734,000 | 222,244,881 | 317,620,406 |
Classification
Type of organization
Public limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.19
Industrial group
Other research and experimental development on natural sciences and engineering
72.190
Industrial group
Other research and experimental development on natural sciences and engineering